Suson, Josatan .
HRN: 16 83 94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/31/2023
08/06/2023
IV
800mg
Q6
T/C Sepsis, Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes